Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
May 10, 2018
| David Gaugh
FDA Approvals: Good News for Patients, More Work to Do (Part 2)
Blog
May 10, 2018
| Chip Davis
Dear Mr. President—On the Eve of Your Drug-Pricing Speech
Blog
May 9, 2018
| David Gaugh
FDA Approvals: Good News for Patients, More Work to Do (Part 1)
Fact Sheet
May 4, 2018
| Erica Klinger
Protect Generic Rx Access for Minnesota Patients
Blog
May 3, 2018
| Christine Simmon
The Biosimilars Council Congressional Briefing: Five Takeaways
Video
May 1, 2018
| Erica Klinger
A Conference You Don't Want to Miss — GRx+Biosims 2018
Report
Apr 26, 2018
| Erica Klinger
Biosimilars Handbook
Blog
Apr 25, 2018
| Rachel Schwartz
Together! Engaging Women in Health Policy
Press Release
Apr 24, 2018
| Rachel Schwartz
AAM Statement on Oil States Energy Services v. Greene's Energy Group
Fact Sheet
Apr 24, 2018
| Erica Klinger
Policy Recommendations to Develop a Robust Biosimilars Market in the U.S.
Fact Sheet
Apr 18, 2018
| Erica Klinger
Amend Connecticut House Bill 5384
Press Release
Apr 18, 2018
| Rachel Schwartz
AAM Announces 2018 Associate Members
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action